In North America, particularly the United States, innovation in menopause care and a modern healthcare infrastructure provide a strong foundation for steady growth at a 3.00% CAGR through 2034. Canada ...

Seaport Therapeutics, a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the presentation of new preclinical ...